Search Results
Found 1 results
510(k) Data Aggregation
(287 days)
CRYO CHECK FACTOR XI DEFICIENT PLASMA, MODEL FDP11-10 (1.OML) AND FDP11-15 (1.5ML)
Cryov Check™ Factor XI Deficient Plasma is recommended for use as a substrate in clot-based Factor XI assays using the activated partial thromboplastin time (APTT).
Cryo Check™ Factor XI Deficient Plasma is frozen human plasma deficient in the Factor XI coagulation factor. It is prepared from citrated pooled normal human plasma which has been depleted of Factor XI by immunoadsorption. Activity levels of Factor XI are assayed at less than 1% normal levels while all other coagulation factors are within normal ranges.
The provided text describes the 510(k) summary for CryoCheck™ Factor XI Deficient Plasma, focusing on its non-clinical performance data for open vial stability.
Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided input:
1. A table of acceptance criteria and the reported device performance
Performance Metric | Acceptance Criteria | Reported Device Performance (Summary Statistics) |
---|---|---|
Mean % Recovery of Factor XI | Mean (+/-) 5% of reference value | 0 Hours: 97.2%, 24 Hours: 96.2%, Average: 96.7% |
Coefficient of Variation (C.V.%) |
Ask a specific question about this device
Page 1 of 1